Tubulis GmbH

Tubulis GmbH

Tubulis generates uniquely matched protein-drug conjugates through the combination of novel proprietary technologies and disease-specific biologic insight. Our goal is to expand the therapeutic potential of antibody-drug conjugates (ADCs) by increasing design flexibility while overcoming constraints of toxicity, efficacy and indication. Tubulis will build new conjugates to fill its growing pipeline and will continue to collaborate with industry partners to usher in a new ADC era and deliver better outcomes for patients.

Yes

Gastrointestinal (Colorectal) Cancer, Genitourinary Cancer, Gynecologic Cancer, Lung Cancer, Antibodies, Biotechnology, Drug Development

Yes